Entera Bio Ltd (NASDAQ:ENTX) price on Thursday, November 14, rose 6.59% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.78.
A look at the stock’s price movement, the close in the last trading session was $1.67, moving within a range at $1.66 and $1.8. Turning to its 52-week performance, $3.35 and $0.52 were the 52-week high and 52-week low respectively. Overall, ENTX moved -2.73% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Entera Bio Ltd’s market cap currently stands at around $65.56 million, with investors looking forward to this quarter’s earnings report slated for in December.
Analysts have a consensus estimate of 40k for the company’s revenue for the quarter, with a low and high estimate of 40k and 40k respectively.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ENTX is a 50% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
ENTX’s current price about -0.88% and -3.78% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 49.17, while 7-day volatility ratio is 6.97% and 5.47% in the 30-day chart. Further, Entera Bio Ltd (ENTX) has a beta value of 1.57, and an average true range (ATR) of 0.10.
If we refocus on Entera Bio Ltd (NASDAQ:ENTX), historical trading data shows that trading volumes averaged 31690.0 over the past 10 days and 32.13K over the past 3 months. The company’s latest data on shares outstanding shows there are 35.48 million shares.
The 19.53% of Entera Bio Ltd’s shares are in the hands of company insiders while institutional holders own 14.71% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 44153.0 on 2024-10-31, giving us a short ratio of 1.98. The data shows that as of 2024-10-31 short interest in Entera Bio Ltd (ENTX) stood at 13.999999999999998 of shares outstanding, with shares short falling to 47169.0 registered in 2024-09-30. Current price change has pushed the stock 196.67% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ENTX stock continues to rise going into the next quarter.
